Androgen insensitivity syndrome
| Androgen insensitivity syndrome | |
 | |
|---|---|
| Testosterone (structure pictured) and dihydrotestosterone to a lesser degree, are the primary androgens involved in AIS. | |
| ICD-10 | E34.5 |
| ICD-9 | 259.5 |
| OMIM | 312300 300068 |
| DiseasesDB | 29662 Template:DiseasesDB2 |
| MeSH | D013734 |
|
Androgen insensitivity syndrome Microchapters |
|
Differentiating Androgen insensitivity syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Androgen insensitivity syndrome On the Web |
|
American Roentgen Ray Society Images of Androgen insensitivity syndrome |
|
Directions to Hospitals Treating Androgen insensitivity syndrome |
|
Risk calculators and risk factors for Androgen insensitivity syndrome |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Androgen resistance syndrome; complete androgen insensitivity; Goldberg-Morris syndrome; testicular feminization syndrome; incomplete androgen insensitivity; partial androgen insensitivity; Reifenstein syndrome; Gilbert-Dreyfus syndrome
Overview
Historical Perspective
Pathophysiology
Differentiating Androgen insensitivity syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Related Chapters
- 17-hydroxylase deficiency syndrome
- 3-beta-hydroxysteroid dehydrogenase deficiency
- 5-alpha-reductase deficiency
- Congenital adrenal hyperplasia
- Mayer-rokitansky syndrome